Viracor Eurofins has been at the forefront of fighting SARS-CoV-2 in the US, launching testing since March 13 using polymerase chain reaction (PCR) with same or next day results for PCR, and 2-4 days for serology testing. The laboratory has available capacity for additional PCR and serology testing at this time and wants to partner locally within the area. On April 6, Viracor Eurofins was granted an Emergency Use Authorization from the US Food and Drug Administration for its Coronavirus SARS-CoV-2 RT-PCR assay. The test utilizes a real-time polymerase chain reaction (RT-PCR) intended for the qualitative detection of SARS-CoV-2 viral RNA in nasopharyngeal (NP) swabs. The laboratory is also working on blood-based serology testing as a tool to identify people who were exposed or may have developed some level of immunity to COVID-19 but potentially had mild to no symptoms. Over time, antibody testing is likely to become a crucial next step in fighting the spread of the virus. The laboratory’s current focus is reaching out to our local communities in Kansas and Missouri that may be in need of testing. If you’re interested in partnering with Viracor for your local testing needs, please contact Phouvieng Saycocie or Michelle Altrich.